Liver cancer remains a significant global health concern, ranking as the sixth most common malignancy and the third leading cause of cancer-related deaths worldwide. Medical imaging plays a vital role in managing liver tumors, particularly hepatocellular carcinoma (HCC) and metastatic lesions. However, the large volume and complexity of imaging data can make accurate and efficient interpretation challenging. Artificial intelligence (AI) is recognized as a promising tool to address these challenges. Therefore, this review aims to explore the recent advances in AI applications in liver tumor imaging, focusing on key areas such as image reconstruction, image quality enhancement, lesion detection, tumor characterization, segmentation, and radiomics. Among these, AI-based image reconstruction has already been widely integrated into clinical workflows, helping to enhance image quality while reducing radiation exposure. While the adoption of AI-assisted diagnostic tools in liver imaging has lagged behind other fields, such as chest imaging, recent developments are driving their increasing integration into clinical practice. In the future, AI is expected to play a central role in various aspects of liver cancer care, including comprehensive image analysis, treatment planning, response evaluation, and prognosis prediction. This review offers a comprehensive overview of the status and prospects of AI applications in liver tumor imaging.

In functional MRI, a hemodynamic response function (HRF) describes how neural events are translated into a blood oxygenation response detected through imaging. The HRF has the potential to quantify neurovascular mechanisms by which cardiovascular risks modify brain health, but relationships among HRF characteristics, brain health, and cardiovascular modifiers of brain health have not been well studied to date. One hundred and thirty-seven middle-aged participants (mean age: 53.6±4.7, female (62%), 78% White American participants and 22% African American participants) in the exploratory analysis from Bogalusa Heart Study completed clinical evaluations from childhood to midlife and an adaptive Stroop task during fMRI in midlife. The HRFs of each participant within seventeen brain regions of interest (ROIs) previously identified as activated by this task were calculated using a convolutional neural network approach. Faster and more efficient neurovascular functioning was characterized in terms of five HRF characteristics: faster time to peak (TTP), shorter full width at half maximum (FWHM), smaller peak magnitude (PM), smaller trough magnitude (TM), and smaller area under the HRF curve (AUHRF). The composite HRF summary characteristics over all ROIs were calculated for multivariable and simple linear regression analyses. In multivariable models, faster and more efficient HRF characteristic was found in non-smoker compared to smokers (AUHRF, p = 0.029). Faster and more efficient HRF characteristics were associated with lower systolic and diastolic blood pressures (FWHM, TM, and AUHRF, p = 0.030, 0.042, and 0.032) and cerebral amyloid burden (FWHM, p-value = 0.027) in midlife; as well as greater response rate on the Stroop task (FWHM, p = 0.042) in midlife. In simple linear regression models, faster and more efficient HRF characteristics were found in women compared to men (TM, p = 0.019); in White American participants compared to African American participants (AUHRF, p = 0.044); and in non-smokers compared to smokers (TTP and AUHRF, p = 0.019 and 0.010). Faster and more efficient HRF characteristics were associated with lower systolic and diastolic blood pressures (FWHM and TM, p = 0.019 and 0.029), and lower BMI (FWHM and AUHRF, p = 0.025 and 0.017), in childhood and adolescence; and lower BMI (TTP, p = 0.049), cerebral amyloid burden (FWHM, p = 0.002), and white matter hyperintensity burden (FWHM, p = 0.046) in midlife; as well as greater accuracy on the Stroop task (AUHRF, p = 0.037) in midlife. In a diverse middle-aged community sample, HRF-based indicators of faster and more efficient neurovascular functioning were associated with better brain health and cognitive function, as well as better lifespan cardiovascular health.

A recently developed method enables automated measurement of the hallux valgus angle (HVA) and the first intermetatarsal angle (IMA) from weight-bearing foot radiographs. This approach employs bone segmentation to identify anatomical landmarks and provides standardized angle measurements based on established guidelines. While effective for HVA and IMA, preoperative radiograph analysis remains complex and requires additional measurements, such as the hallux interphalangeal angle (IPA), which has received limited research attention. To expand the previous method, which measured HVA and IMA, by incorporating the automatic measurement of IPA, evaluating its accuracy and clinical relevance. A preexisting database of manually labeled foot radiographs was used to train a U-Net neural network for segmenting bones and identifying landmarks necessary for IPA measurement. Of the 265 radiographs in the dataset, 161 were selected for training and 20 for validation. The U-Net neural network achieves a high mean Sørensen-Dice index (> 0.97). The remaining 84 radiographs were used to assess the reliability of automated IPA measurements against those taken manually by two orthopedic surgeons (O_A and O_B) using computer-based tools. Each measurement was repeated to assess intraobserver (O_A1 and O_A2) and interobserver (O_A2 and O_B) reliability. Agreement between automated and manual methods was evaluated using the Intraclass Correlation Coefficient (ICC), and Bland-Altman analysis identified systematic differences. Standard error of measurement (SEM) and Pearson correlation coefficients quantified precision and linearity, and measurement times were recorded to evaluate efficiency. The artificial intelligence (AI)-based system demonstrated excellent reliability, with ICC3.1 values of 0.92 (AI <i>vs</i> O_A2) and 0.88 (AI <i>vs</i> O_B), both statistically significant (<i>P</i> < 0.001). For manual measurements, ICC values were 0.95 (O_A2 <i>vs</i> O_A1) and 0.95 (O_A2 <i>vs</i> O_B), supporting both intraobserver and interobserver reliability. Bland-Altman analysis revealed minimal biases of: (1) 1.61° (AI <i>vs</i> O_A2); and (2) 2.54° (AI <i>vs</i> O_B), with clinically acceptable limits of agreement. The AI system also showed high precision, as evidenced by low SEM values: (1) 1.22° (O_A2 <i>vs</i> O_B); (2) 1.77° (AI <i>vs</i> O_A2); and (3) 2.09° (AI <i>vs</i> O_B). Furthermore, Pearson correlation coefficients confirmed strong linear relationships between automated and manual measurements, with <i>r</i> = 0.85 (AI <i>vs</i> O_A2) and <i>r</i> = 0.90 (AI <i>vs</i> O_B). The AI method significantly improved efficiency, completing all 84 measurements 8 times faster than manual methods, reducing the time required from an average 36 minutes to just 4.5 minutes. The proposed AI-assisted IPA measurement method shows strong clinical potential, effectively corresponding with manual measurements. Integrating IPA with HVA and IMA assessments provides a comprehensive tool for automated forefoot deformity analysis, supporting hallux valgus severity classification and preoperative planning, while offering substantial time savings in high-volume clinical settings.

Alzheimer's disease (AD) is a leading cause of death, making early detection critical to improve survival rates. Conventional manual techniques struggle with early diagnosis due to the brain's complex structure, necessitating the use of dependable deep learning (DL) methods. This research proposes a novel RESIGN model is a combination of Res-InceptionSeg for detecting AD utilizing MRI images. The input MRI images were pre-processed using a Non-Local Means (NLM) filter to reduce noise artifacts. A ResNet-LSTM model was used for feature extraction, targeting White Matter (WM), Grey Matter (GM), and Cerebrospinal Fluid (CSF). The extracted features were concatenated and classified into Normal, MCI, and AD categories using an Inception V3-based classifier. Additionally, SegNet was employed for abnormal brain region segmentation. The RESIGN model achieved an accuracy of 99.46%, specificity of 98.68%, precision of 95.63%, recall of 97.10%, and an F1 score of 95.42%. It outperformed ResNet, AlexNet, Dense- Net, and LSTM by 7.87%, 5.65%, 3.92%, and 1.53%, respectively, and further improved accuracy by 25.69%, 5.29%, 2.03%, and 1.71% over ResNet18, CLSTM, VGG19, and CNN, respectively. The integration of spatial-temporal feature extraction, hybrid classification, and deep segmentation makes RESIGN highly reliable in detecting AD. A 5-fold cross-validation proved its robustness, and its performance exceeded that of existing models on the ADNI dataset. However, there are potential limitations related to dataset bias and limited generalizability due to uniform imaging conditions. The proposed RESIGN model demonstrates significant improvement in early AD detection through robust feature extraction and classification by offering a reliable tool for clinical diagnosis.

Prostate cancer (PCa) is one of the most common types of cancer, seriously affecting adult male health. Accurate and automated PCa segmentation is essential for radiologists to confirm the location of cancer, evaluate its severity, and design appropriate treatments. This paper presents PCaSAM, a fully automated PCa segmentation model that allows us to input multi-modal MRI images into the foundation model to improve performance significantly. We collected multi-center datasets to conduct a comprehensive evaluation. The results showed that PCaSAM outperforms the generalist medical foundation model and the other representative segmentation models, with the average DSC of 0.721 and 0.706 in the internal and external datasets, respectively. Furthermore, with the assistance of segmentation, the PI-RADS scoring of PCa lesions was improved significantly, leading to a substantial increase in average AUC by 8.3-8.9% on two external datasets. Besides, PCaSAM achieved superior efficiency, making it highly suitable for real-world deployment scenarios.

Recent advancements in diffusion probabilistic models (DPMs) have revolutionized image processing, demonstrating significant potential in medical applications. Accurate segmentation of the left ventricle (LV) in echocardiograms is crucial for diagnostic procedures and necessary treatments. However, ultrasound images are notoriously noisy with low contrast and ambiguous LV boundaries, thereby complicating the segmentation process. To address these challenges, this paper introduces Echo-DND, a novel dual-noise diffusion model specifically designed for this task. Echo-DND leverages a unique combination of Gaussian and Bernoulli noises. It also incorporates a multi-scale fusion conditioning module to improve segmentation precision. Furthermore, it utilizes spatial coherence calibration to maintain spatial integrity in segmentation masks. The model's performance was rigorously validated on the CAMUS and EchoNet-Dynamic datasets. Extensive evaluations demonstrate that the proposed framework outperforms existing SOTA models. It achieves high Dice scores of 0.962 and 0.939 on these datasets, respectively. The proposed Echo-DND model establishes a new standard in echocardiogram segmentation, and its architecture holds promise for broader applicability in other medical imaging tasks, potentially improving diagnostic accuracy across various medical domains. Project page: https://abdur75648.github.io/Echo-DND

Deep learning-based myocardial scar segmentation from late gadolinium enhancement (LGE) cardiac MRI has shown great potential for accurate and timely diagnosis and treatment planning for structural cardiac diseases. However, the limited availability and variability of LGE images with high-quality scar labels restrict the development of robust segmentation models. To address this, we introduce CLAIM: \textbf{C}linically-Guided \textbf{L}GE \textbf{A}ugmentation for Real\textbf{i}stic and Diverse \textbf{M}yocardial Scar Synthesis and Segmentation framework, a framework for anatomically grounded scar generation and segmentation. At its core is the SMILE module (Scar Mask generation guided by cLinical knowledgE), which conditions a diffusion-based generator on the clinically adopted AHA 17-segment model to synthesize images with anatomically consistent and spatially diverse scar patterns. In addition, CLAIM employs a joint training strategy in which the scar segmentation network is optimized alongside the generator, aiming to enhance both the realism of synthesized scars and the accuracy of the scar segmentation performance. Experimental results show that CLAIM produces anatomically coherent scar patterns and achieves higher Dice similarity with real scar distributions compared to baseline models. Our approach enables controllable and realistic myocardial scar synthesis and has demonstrated utility for downstream medical imaging task.

Cancer is an abnormal growth with potential to invade locally and metastasize to distant organs. Accurate auto-segmentation of the tumor and surrounding normal tissues is required for radiotherapy treatment plan optimization. Recent AI-based segmentation models are generally trained on large public datasets, which lack the heterogeneity of local patient populations. While these studies advance AI-based medical image segmentation, research on local datasets is necessary to develop and integrate AI tumor segmentation models directly into hospital software for efficient and accurate oncology treatment planning and execution. This study enhances tumor segmentation using computationally efficient hybrid UNet-Transformer models on magnetic resonance imaging (MRI) datasets acquired from a local hospital under strict privacy protection. We developed a robust data pipeline for seamless DICOM extraction and preprocessing, followed by extensive image augmentation to ensure model generalization across diverse clinical settings, resulting in a total dataset of 6080 images for training. Our novel architecture integrates UNet-based convolutional neural networks with a transformer bottleneck and complementary attention modules, including efficient attention, Squeeze-and-Excitation (SE) blocks, Convolutional Block Attention Module (CBAM), and ResNeXt blocks. To accelerate convergence and reduce computational demands, we used a maximum batch size of 8 and initialized the encoder with pretrained ImageNet weights, training the model on dual NVIDIA T4 GPUs via checkpointing to overcome Kaggle's runtime limits. Quantitative evaluation on the local MRI dataset yielded a Dice similarity coefficient of 0.764 and an Intersection over Union (IoU) of 0.736, demonstrating competitive performance despite limited data and underscoring the importance of site-specific model development for clinical deployment.

The long-term association between adrenal gland volume (AGV) and type 2 diabetes (T2D) remains unclear. We aimed to determine the association between deep learning-based AGV and current glycemic status and incident T2D. In this observational study, adults who underwent abdominopelvic computed tomography (CT) for health checkups (2011-2012), but had no adrenal nodules, were included. AGV was measured from CT images using a three-dimensional nnU-Net deep learning algorithm. We assessed the association between AGV and T2D using a cross-sectional and longitudinal design. We used 500 CT scans (median age, 52.3 years; 253 men) for model development and a Multi-Atlas Labeling Beyond the Cranial Vault dataset for external testing. A clinical cohort included a total of 9708 adults (median age, 52.0 years; 5,769 men). The deep learning model demonstrated a dice coefficient of 0.71±0.11 for adrenal segmentation and a mean volume difference of 0.6± 0.9 mL in the external dataset. Participants with T2D at baseline had a larger AGV than those without (7.3 cm3 vs. 6.7 cm3 and 6.3 cm3 vs. 5.5 cm3 for men and women, respectively, all P<0.05). The optimal AGV cutoff values for predicting T2D were 7.2 cm3 in men and 5.5 cm3 in women. Over a median 7.0-year follow-up, T2D developed in 938 participants. Cumulative T2D risk was accentuated with high AGV compared with low AGV (adjusted hazard ratio, 1.27; 95% confidence interval, 1.11 to 1.46). AGV, measured using deep learning algorithms, is associated with current glycemic status and can significantly predict the development of T2D.

Transarterial Chemoembolization (TACE) is a widely applied alternative treatment for patients with hepatocellular carcinoma who are not eligible for liver resection or transplantation. However, the clinical outcomes after TACE are highly heterogeneous. There remains an urgent need for effective and efficient strategies to accurately assess tumor response and predict long-term outcomes using longitudinal and multi-center datasets. To address this challenge, we here introduce RECIST^Surv, a novel response-driven Transformer model that integrates multi-task learning with a response-driven co-attention mechanism to simultaneously perform liver and tumor segmentation, predict tumor response to TACE, and estimate overall survival based on longitudinal Computed Tomography (CT) imaging. The proposed Response-driven Co-attention layer models the interactions between pre-TACE and post-TACE features guided by the treatment response embedding. This design enables the model to capture complex relationships between imaging features, treatment response, and survival outcomes, thereby enhancing both prediction accuracy and interpretability. In a multi-center validation study, RECIST^Surv-predicted prognosis has demonstrated superior precision than state-of-the-art methods with C-indexes ranging from 0.595 to 0.780. Furthermore, when integrated with multi-modal data, RECIST^Surv has emerged as an independent prognostic factor in all three validation cohorts, with hazard ratio (HR) ranging from 1.693 to 20.7 (P = 0.001-0.042). Our results highlight the potential of RECIST^Surv as a powerful tool for personalized treatment planning and outcome prediction in hepatocellular carcinoma patients undergoing TACE. The experimental code is made publicly available at https://github.com/rushier/RECISTSurv.